Y H Lee1, S-C Bae2. 1. Division of Rheumatology, Department of Internal Medicine Korea University Anam Hospital, Korea University College of Medicine, 73, Inchon-ro, Seongbuk-gu, 02841, Seoul, Korea. lyhcgh@korea.ac.kr. 2. The Hospital for Rheumatic Diseases, Hanyang University Medical Center, Seoul, Korea.
Abstract
OBJECTIVE: This study aimed to evaluate the relationship between telomere length and rheumatoid arthritis (RA). METHODS: We performed a meta-analysis of studies comparing the telomere length in RA patients and healthy controls, and conducted subgroup analysis based on ethnicity, age-matched status, study quality, sample type, assay method, subject number, and shared epitope (SE) status. RESULTS: Nine studies from seven articles, with 388 RA patients and 362 controls, were included. Meta-analysis showed that the telomere length was significantly shorter in all individuals of the RA group than in those of the control group (SMD = -0.833, 95 % CI = -1.332 to -0.334, p = 0.001). Stratification by ethnicity showed significantly shortened telomere lengths in both mixed and age-matched Caucasian populations with RA (SMD = -1.415, 95 % CI = -1.709 to -1.120, p < 1.0 × 10-8; SMD = -0.658, 95 % CI = -1.187 to -0.0.128, p = 0.015). The telomere length was significantly shorter in the RA group than in the age-matched control group; however, this was not the case in the RA group that was not age-matched (SMD = -1.070, 95 % CI = -1.489 to -0.650, p = 5.7 × 10-7; SMD = 0.155, 95 % CI = -0.119 to 0.429, p = 0.267). Stratification by SE status revealed a significantly shortened telomere length in the SE-positive group, but not in the SE-negative group (SMD = -1.033, 95 % CI = -1.398 to -0.768, p < 1.0 × 10-8; SMD = -0.967, 95 % CI = -2.382 to 0.449, p = 0.181). In addition, the telomere length was significantly shorter in the SE-positive RA group than in the SE-negative RA group (SMD = -0.415, 95 % CI = -0.699 to -0.131, p = 0.004). CONCLUSIONS: Our meta-analysis demonstrated that the telomere length was significantly shorter in patients with RA, and was significantly more so in the SE-positive group than in the SE-negative group.
OBJECTIVE: This study aimed to evaluate the relationship between telomere length and rheumatoid arthritis (RA). METHODS: We performed a meta-analysis of studies comparing the telomere length in RA patients and healthy controls, and conducted subgroup analysis based on ethnicity, age-matched status, study quality, sample type, assay method, subject number, and shared epitope (SE) status. RESULTS: Nine studies from seven articles, with 388 RA patients and 362 controls, were included. Meta-analysis showed that the telomere length was significantly shorter in all individuals of the RA group than in those of the control group (SMD = -0.833, 95 % CI = -1.332 to -0.334, p = 0.001). Stratification by ethnicity showed significantly shortened telomere lengths in both mixed and age-matched Caucasian populations with RA (SMD = -1.415, 95 % CI = -1.709 to -1.120, p < 1.0 × 10-8; SMD = -0.658, 95 % CI = -1.187 to -0.0.128, p = 0.015). The telomere length was significantly shorter in the RA group than in the age-matched control group; however, this was not the case in the RA group that was not age-matched (SMD = -1.070, 95 % CI = -1.489 to -0.650, p = 5.7 × 10-7; SMD = 0.155, 95 % CI = -0.119 to 0.429, p = 0.267). Stratification by SE status revealed a significantly shortened telomere length in the SE-positive group, but not in the SE-negative group (SMD = -1.033, 95 % CI = -1.398 to -0.768, p < 1.0 × 10-8; SMD = -0.967, 95 % CI = -2.382 to 0.449, p = 0.181). In addition, the telomere length was significantly shorter in the SE-positive RA group than in the SE-negative RA group (SMD = -0.415, 95 % CI = -0.699 to -0.131, p = 0.004). CONCLUSIONS: Our meta-analysis demonstrated that the telomere length was significantly shorter in patients with RA, and was significantly more so in the SE-positive group than in the SE-negative group.
Authors: Kathryn K Ridout; Samuel J Ridout; Lawrence H Price; Srijan Sen; Audrey R Tyrka Journal: J Affect Disord Date: 2015-12-02 Impact factor: 4.839
Authors: M Honda; E Mengesha; S Albano; W S Nichols; D J Wallace; A Metzger; J R Klinenberg; M Linker-Israeli Journal: Clin Immunol Date: 2001-05 Impact factor: 3.969
Authors: María Tamayo; Alejandro Mosquera; José Ignacio Rego; José Luis Fernández-Sueiro; Francisco J Blanco; José Luis Fernández Journal: Mutat Res Date: 2010-01-05 Impact factor: 2.433
Authors: Laura E Petersen; Jaqueline B Schuch; Lucas A de Azeredo; Talita S A Baptista; Julia G Motta; Aline D do Prado; Moisés Evandro Bauer Journal: Clin Rheumatol Date: 2019-06-11 Impact factor: 2.980
Authors: Anna R Smith; Pi-I D Lin; Sheryl L Rifas-Shiman; Mohammad L Rahman; Diane R Gold; Andrea A Baccarelli; Birgit Claus Henn; Chitra Amarasiriwardena; Robert O Wright; Brent Coull; Marie-France Hivert; Emily Oken; Andres Cardenas Journal: Environ Health Perspect Date: 2021-11-19 Impact factor: 9.031